Cargando…
Corrigendum to “PI3K Inhibition Augments the Therapeutic Efficacy of a 3a–aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells [Translational Oncology 7 (2014) 256–266.e5]
Autores principales: | Sanjiv, Kumar, Chen, Chi-Wei, Kakadiya, Rajesh, Tala, Satishkumar, Suman, Sharda, Wu, Ming-Hsi, Chen, Yen-Hui, Su, Tsann-Long, Lee, Te-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348211/ https://www.ncbi.nlm.nih.gov/pubmed/28292510 http://dx.doi.org/10.1016/j.tranon.2016.12.010 |
Ejemplares similares
-
PI3K Inhibition Augments the Therapeutic Efficacy of a 3a-aza-Cyclopenta[α]indene Derivative in Lung Cancer Cells()()
por: Sanjiv, Kumar, et al.
Publicado: (2014) -
Corrigendum to “A Potent Derivative of Indolizino[6,7-b]Indole for Treatment of Human Non–Small Cell Lung Cancer Cells” [Neoplasia 18 (2016) 199-212]
por: Chen, Chi-Wei, et al.
Publicado: (2016) -
Synthetic Access to Cyclopenta[a]inden-2(1H)-ones from Morita–Baylis–Hillman
Products of 2-Alkynyl Benzaldehydes
por: Raji Reddy, Chada, et al.
Publicado: (2018) -
Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy [Volume 37, Issue 3, September 2018, Pages 248–256]
por: Song, Eun Joo, et al.
Publicado: (2018) -
Corrigendum to “Can sliding-window correlations reveal dynamic functional connectivity in resting-state fMRI?” [NeuroImage 127 (2016) 242–256]
por: Hindriks, R., et al.
Publicado: (2016)